share_log

Private Companies Invested in Urovo Technology Co., Ltd. (SZSE:300531) Copped the Brunt of Last Week's CN¥380m Market Cap Decline

先週の3.8億元の時価総額減少の被害を蒙ったのは、有限会社のURoboテクノロジー株式会社(SZSE:300531)に投資した企業です。

Simply Wall St ·  2023/09/15 18:21

Key Insights

  • Significant control over Urovo Technology by private companies implies that the general public has more power to influence management and governance-related decisions
  • A total of 6 investors have a majority stake in the company with 50% ownership
  • Using data from company's past performance alongside ownership research, one can better assess the future performance of a company

A look at the shareholders of Urovo Technology Co., Ltd. (SZSE:300531) can tell us which group is most powerful. We can see that private companies own the lion's share in the company with 42% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

And following last week's 8.0% decline in share price, private companies suffered the most losses.

Let's delve deeper into each type of owner of Urovo Technology, beginning with the chart below.

Check out our latest analysis for Urovo Technology

ownership-breakdown
SZSE:300531 Ownership Breakdown September 15th 2023

What Does The Institutional Ownership Tell Us About Urovo Technology?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

As you can see, institutional investors have a fair amount of stake in Urovo Technology. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Urovo Technology's historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
SZSE:300531 Earnings and Revenue Growth September 15th 2023

Hedge funds don't have many shares in Urovo Technology. The company's largest shareholder is Urovo Technology (Hong Kong) Holdings Limited, with ownership of 35%. The second and third largest shareholders are Zhuhai Gejin No. 8 Equity Investment Fund Partnership (Limited Partnership) and Zhuhai Gree Equity Investment Fund Management Co., Ltd., with an equal amount of shares to their name at 5.1%. In addition, we found that Song Guo, the CEO has 1.7% of the shares allocated to their name.

On further inspection, we found that more than half the company's shares are owned by the top 6 shareholders, suggesting that the interests of the larger shareholders are balanced out to an extent by the smaller ones.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track.

Insider Ownership Of Urovo Technology

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

Shareholders would probably be interested to learn that insiders own shares in Urovo Technology Co., Ltd.. It has a market capitalization of just CN¥4.4b, and insiders have CN¥115m worth of shares, in their own names. Some would say this shows alignment of interests between shareholders and the board. But it might be worth checking if those insiders have been selling.

General Public Ownership

The general public-- including retail investors -- own 42% stake in the company, and hence can't easily be ignored. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Private Equity Ownership

With a stake of 5.1%, private equity firms could influence the Urovo Technology board. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.

Private Company Ownership

It seems that Private Companies own 42%, of the Urovo Technology stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important.

I always like to check for a history of revenue growth. You can too, by accessing this free chart of historic revenue and earnings in this detailed graph.

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする